OR WAIT null SECS
June 25, 2024
The Hopewell facility—which will serve as the CDMO’s North American hub—is expected to help accelerate the cell and gene therapy delivery process.
June 24, 2024
In an interview with Pharma Commerce Editor Nicholas Saraceno, Fran Gregory, PharmD, Vice President of Emerging Therapies, Cardinal Health, discusses ways that changes made to reimbursement models are affecting patient therapies in the biosimilar space.
June 12, 2024
A retrospective cohort study investigates the characteristics of female patients with localized breast cancer that are associated with this nonpersistence.
June 10, 2024
A cohort study explores the connection between the rise in Medicare Advantage plan coverage and enrollee satisfaction.
June 07, 2024
By marrying real-world evidence and AI, pharma stakeholders can identify new opportunities to tailor interventions in a way that is most impactful to patients—helping them overcome roadblocks in initiating and maintaining therapy.
Companies need to alter their thinking to better prioritize patients. Here are three simple yet impactful engagement elements that could help.
June 06, 2024
Ashfield Event Experiences and WRG merge in an effort to better serve the healthcare industry.
If Congress doesn't act soon, it could result in more health inequities.
June 04, 2024
A retrospective study explores the connection between adherence and racial/ethnic disparities among patients with Alzheimer’s disease, along with similar dementias.
May 28, 2024
Among its benefits, the fund will provide up to $8,000 in medication copayment or insurance premium assistance.